|
|
Elevance Health Inc (NYSE: ELV) |
|
Price: $407.5000
$-7.28 
-1.755%
|
| Day's High:
| $414.4599914550781
| Week Perf:
| 3.81 %
|
| Day's Low: |
$ 406.34 |
30 Day Perf: |
4.11 % |
| Volume (M): |
1,041,948 |
52 Wk High: |
$ 436.24 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$353.26 |
| Open: |
$411.12 |
52 Wk Low: |
$274.84 |
|
|
| Market Capitalization (Millions $) |
89,813 |
| Shares
Outstanding (Millions) |
220 |
| Employees |
97,100 |
| Revenues (TTM) (Millions $) |
200,415 |
| Net Income (TTM) (Millions $) |
5,237 |
| Cash Flow (TTM) (Millions $) |
2,157 |
| Capital Exp. (TTM) (Millions $) |
1,155 |
Business Description
Elevance Health Inc is a healthcare technology company that offers digital solutions to improve healthcare outcomes for patients and reduce administrative burdens for healthcare providers. The company offers a comprehensive suite of tools including payment automation, data analytics, patient engagement, and clinical decision support systems, among others.
Founded in 2015, Elevance Health has a mission to streamline the healthcare system by leveraging the latest in technology to overcome the challenges in the industry. They are focused on developing intelligent software solutions that bring automation, simplification, and precision to healthcare administration, making it easier for healthcare providers to deliver quality care to patients and achieve better outcomes.
One of the most notable solutions offered by Elevance Health is its payment automation platform, which helps healthcare providers to submit and process medical bills and insurance claims efficiently. The platform is designed to automate insurance verification, claim submission, and payment processing, reducing the potential for billing errors, improving payment turnaround times, and increasing revenue for healthcare providers.
Elevance Health also offers data analytic tools that allow healthcare providers to gain insights into patient populations, track performance against quality measures, and identify areas for improvement. The platform provides custom reports and dashboards, allowing healthcare providers to monitor key performance indicators and gain actionable insights that can inform decision-making.
The company's patient engagement solutions are also notable, as they leverage advanced technologies to improve communication between patients and healthcare providers. This includes patient portal solutions that allow patients to access their medical records, communicate with their doctors, and schedule appointments through a convenient online platform.
Overall, Elevance Health Inc is a healthcare technology company that is dedicated to improving healthcare outcomes through innovative software solutions. With a focus on payment automation, data analytics, patient engagement, and clinical decision support, Elevance Health is helping healthcare providers to streamline their workflows, reduce administrative burdens, and improve the quality of care they deliver to patients.
Company Address: 220 Virginia Avenue Indianapolis 46204 IN
Company Phone Number: 401-1577 Stock Exchange / Ticker: NYSE ELV
|
|
|
Customers Net Income grew by |
ELV's Customers Net Profit Margin grew to |
56.97 % |
3.79 %
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Mon, Nov 4 2024 8:36 PM UTC
Elevance Health Inc. has made a notable change in its leadership by appointing Nathan Rich as the new Vice President of Investor Relations. This appointment comes at a pivotal time for the health care company, which has recently reported its financial performance for the third quarter of 2024.In its latest quarterly report, Elevance Health achieved a return on average invest...
|
| Business Update
Published Mon, Aug 12 2024 4:47 PM UTC
In the ever-evolving landscape of healthcare and health insurance, Elevance Health Inc. stands out not only for its market presence but also for its commitment to enhancing health outcomes through innovative metrics. The company s recent unveiling of its Whole Health Index serves as a pivotal moment, demonstrating potential opportunities for improving overall health, even in...
|
| Dividend
Published Thu, Jul 18 2024 2:14 AM UTC
Elevance Health Reports Strong Second Quarter Results and Maintains Full-Year Outlook
Elevance Health, Inc. (NYSE: ELV) recently announced its second quarter 2024 results, demonstrating the success of its diversified business and strategic initiatives amidst a challenging industry landscape. The company remains focused on its mission to enhance human health and has prude...
|
| Dividend
Published Wed, Jul 17 2024 12:57 PM UTC
Elevance Health Reports Strong Second Quarter Results - Stock Price on the Rise
Elevance Health, Inc. (NYSE: ELV) recently announced their second quarter 2024 results, showcasing the success of their diversified business strategy amidst a challenging industry landscape. The company s commitment to improving the health of humanity has driven their strategic initiatives, r...
|
| Contract
Published Mon, Apr 15 2024 11:00 AM UTC
Elevance Health, a leading healthcare company, has recently signed an agreement with Clayton, Dubilier & Rice (CD&R), a global private investment firm, to launch a strategic partnership aimed at advancing primary care delivery. This collaboration between the two influential companies seeks to accelerate innovation, enhance the healthcare experience, and ultimately improve he...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
23.48 $ |
| Revenues (TTM) |
909.32 $
|
| Cash Flow (TTM) |
9.79 $ |
| Cash |
161.35 $
|
| Book Value |
199.83 $
|
| Dividend (TTM) |
6.85 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
2,064,006 |
| Net
Income per Employee (TTM) |
53,934 |
| Receivable Turnover Ratio (TTM) |
- |
| Inventory Turnover Ratio (TTM) |
- |
| Asset Turnover Ratio (TTM) |
1.61 |
|
|
| Per Share |
|
| Earnings (TTM) |
23.48 $
|
| Revenues (TTM) |
909.32 $ |
| Cash Flow (TTM) |
9.79 $ |
| Cash |
161.35 $
|
| Book Value |
199.83 $ |
| Dividend (TTM) |
6.85 $ |
|
|
| |
| Product revenue |
|
 12.41 % |
of total Revenue |
| Service fees |
|
4.47 % |
of total Revenue |
| Eliminations |
|
-21.85 % |
of total Revenue |
| Health Benefits |
|
84.67 % |
of total Revenue |
| Health Benefits Service fees |
|
4.06 % |
of total Revenue |
| Total Carelon |
|
35.8 % |
of total Revenue |
| Total Carelon Product revenue |
|
12.41 % |
of total Revenue |
| Total Carelon Service fees |
|
0.41 % |
of total Revenue |
| CarelonRx |
|
21.12 % |
of total Revenue |
| CarelonRx Product revenue |
|
12.41 % |
of total Revenue |
| CarelonRx Service fees |
|
0.01 % |
of total Revenue |
| Carelon Services |
|
14.68 % |
of total Revenue |
| Carelon Services Service fees |
|
0.4 % |
of total Revenue |
| Corporate Other |
|
0.01 % |
of total Revenue |
| revenue - unaffiliated |
|
98.63 % |
of total Revenue |
| revenue - unaffiliated Eliminations |
|
-0.41 % |
of total Revenue |
| revenue - unaffiliated Health Benefits |
|
84.67 % |
of total Revenue |
| revenue - unaffiliated Total Carelon |
|
14.37 % |
of total Revenue |
| revenue - unaffiliated CarelonRx |
|
12.41 % |
of total Revenue |
| revenue - unaffiliated Carelon Services |
|
1.96 % |
of total Revenue |
| revenue - affiliated Eliminations |
|
-21.44 % |
of total Revenue |
| revenue - affiliated Total Carelon |
|
21.43 % |
of total Revenue |
| revenue - affiliated CarelonRx |
|
8.71 % |
of total Revenue |
| revenue - affiliated Carelon Services |
|
12.72 % |
of total Revenue |
| revenue - affiliated Corporate Other |
|
0.01 % |
of total Revenue |
| Reportable Segments |
|
100 % |
of total Revenue |
| |
On June 27 2024 the Elevance Health Inc provided following guidance
Elevance Health Inc. (NYSE: ELV) anticipates releasing its financial results for the second quarter of 2024 on July 17th, 2024, at 6:00 a.m. EDT. Following the release, a conference call is scheduled to take place at 8:30 a.m. EDT on the same day. During the call, management will discuss the financial results and provide insights into the company's outlook moving forward.
To join the conference call, participants are required to dial in at least 15 minutes prior to the scheduled start time using the following numbers: 888-947-9963 for domestic participants with the access code 3972058, and 312-470-0178 for international participants with the same access code 3972058.
Investors, s, and o...
|
|
|
1.31%